What to Know About Weight Loss Patches
Similar results were reported by Wang et al., where GLP-1 RA treatment had a notable impact on the abundance of weight-related microbial phylotypes, though no significant change in the Firmicutes/Bacteroidetes ratio was observed (72)
Although not thought to be directly influenced by obesity, lipoprotein (a) is an independent risk factor for cardiovascular disease that is determined by genetics
Research is currently underway to see if taking oral weight-loss medication (such as bupropion-naltrexone) can help ease the transition off GLP-1 receptor agonists and reduce the amount of weight that's typically regained after stopping them
Having gone through it myself, I can relate to both the excitement of the results and the desire to feel like everything matches how good you feel, Dana says
Additional Research Areas Where Retatrutide May Benefit Phase 3 TRIUMPH trials study osteoarthritis, cardiovascular risk, kidney disease, and MASH